Serum Cytokine of IL-10 and IL-12 in Chronic Liver Disease: The Immune and Inflammatory Response

Table 3

IL-10 and IL-12 serum expression in chronic liver disease with HCV infection.

	+ve HCV-chronic liver disease				−ve HCV-chronic liver disease				NDC
	PCH	LC	HCC	Total	PCH	LC	HCC	Total
IL-10; (ng/mL)	6.437; ± 0.518	14.49; ± 0.615	16.39; ± 1.015	13.169; ± 4.02	6.6; ± 1.13	13.0; ± 0.14	15.4; ± 1.16	12.61; ± 3.95	6.04 ± 0.568
IL-12; (ng/mL)	484.875; ± 16.23	501.86; ± 19.1	656.45; ± 17.1	549.27; ± 79.15	499.0; ± 22.63	533.5; ± 2.12	658.25; ± 27.035	587.3; ± 79.5	258.4 ± 14.06

IL-10 expression showed significant difference in HCV-infected () and noninfected patients () compared to nondisease control.
IL-12 expression showed significant difference in HCV-infected and noninfected patients () compared to nondisease control.
+ve HCV-chronic liver disease shows that there is asymptotic significance () within groups (Kruskal-Wallis test) and the difference between groups was detected by Mann-Whitney showing that there is a significant () difference between each group and the other one.